Constellium SE (NYSE:CSTM) Receives $35.80 Consensus PT from Brokerages

Constellium SE (NYSE:CSTM) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $35.80.

Several research firms have recently commented on CSTM. Wells Fargo & Company boosted their price target on shares of Constellium from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft set a $39.00 price objective on shares of Constellium in a research note on Thursday, July 30th. UBS Group cut their price objective on shares of Constellium from $38.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, July 8th. Weiss Ratings downgraded shares of Constellium from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, July 1st. Finally, Zacks Research lowered Constellium from a “strong-buy” rating to a “hold” rating in a report on Monday, June 29th.

Constellium Stock Performance

Shares of Constellium stock opened at $26.83 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.61 and a debt-to-equity ratio of 1.50. The stock’s fifty day moving average price is $28.99 and its 200-day moving average price is $29.34. The firm has a market cap of $3.64 billion, a P/E ratio of 6.91 and a beta of 1.55. Constellium has a 12 month low of $13.58 and a 12 month high of $36.99.

Constellium (NYSE:CSTM) last released its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.18. Constellium had a net margin of 5.69% and a return on equity of 51.66%. The company had revenue of $2.75 billion during the quarter, compared to analyst estimates of $2.73 billion. During the same period in the prior year, the firm earned $0.25 earnings per share. The firm’s revenue for the quarter was up 30.7% compared to the same quarter last year. On average, equities research analysts expect that Constellium will post 3.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director John Ormerod sold 8,000 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $35.01, for a total value of $280,080.00. Following the completion of the transaction, the director directly owned 24,873 shares of the company’s stock, valued at approximately $870,803.73. The trade was a 24.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jean-Christophe Deslarzes purchased 1,490 shares of Constellium stock in a transaction dated Monday, August 3rd. The stock was bought at an average cost of $27.24 per share, with a total value of $40,587.60. Following the completion of the transaction, the director owned 43,515 shares in the company, valued at approximately $1,185,348.60. This represents a 3.55% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.20% of the company’s stock.

Hedge Funds Weigh In On Constellium

Large investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System boosted its holdings in shares of Constellium by 3,014.9% in the 2nd quarter. California State Teachers Retirement System now owns 4,539,372 shares of the industrial products company’s stock valued at $142,434,000 after buying an additional 4,393,640 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of Constellium by 620.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company’s stock worth $79,345,000 after acquiring an additional 2,780,260 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in Constellium by 894.4% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company’s stock valued at $50,545,000 after acquiring an additional 1,849,554 shares during the last quarter. Millennium Management LLC boosted its stake in Constellium by 35.4% in the third quarter. Millennium Management LLC now owns 6,935,766 shares of the industrial products company’s stock valued at $103,204,000 after acquiring an additional 1,813,400 shares in the last quarter. Finally, Morgan Stanley boosted its stake in Constellium by 48.4% in the fourth quarter. Morgan Stanley now owns 3,728,118 shares of the industrial products company’s stock valued at $70,275,000 after acquiring an additional 1,216,516 shares in the last quarter. 92.59% of the stock is currently owned by institutional investors.

Constellium Company Profile

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.